Healthlynked CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OQB
George O'Leary, Chief Financial Officer and a Director of HealthLynked Corp, received 35,000 shares of common stock on July 22, 2026.
OQB
HealthLynked Corp's CEO, Michael Dent, reports the acquisition of convertible notes through a trust.
OQB
Michael Dent, CEO of HealthLynked Corp, reports the acquisition of convertible notes through a trust.
OQB
Michael Dent, CEO of HealthLynked Corp, reports the acquisition of convertible notes through a trust.
OQB
Form 4: HealthLynked CEO Michael Dent Reports Acquisition of Convertible Notes and Expiration of Warrants
Michael Dent, CEO of HealthLynked Corp, reports the acquisition of convertible notes through a trust and the expiration of warrants.
OQB
CEO Michael Dent reports the acquisition of convertible notes and warrants through a trust, signaling continued investment in HealthLynked Corp.
OQB
Michael Dent, CEO of HealthLynked Corp, acquired warrants to purchase 393,750 shares of common stock as partial consideration for extending a convertible promissory note.
OQB
David Rosal, CFO of HealthLynked Corp, reports acquiring common stock through open market purchases.
OQB
HealthLynked Corp's CEO, Michael Dent, through a trust, acquired a convertible note and warrants, signaling potential future equity stake.
OQB
HealthLynked Corp's CEO, Michael Dent, through a trust, acquired $150,000 in 12% Convertible Notes on April 10, 2024.
OQB
HealthLynked Corp's CEO, Michael Dent, reports the acquisition of warrants and convertible notes through a trust, along with employee stock options.